National Healthcare Properties, Inc. (NHP) operates as a real estate investment trust (REIT), concentrating its efforts on acquiring, owning, and overseeing a ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $0.48 · Revenue $363.03M · 1 analysts
Est. EPS $0.05 · Revenue $425.36M · 2 analysts
Est. EPS $0.06 · Revenue $127.49M · 1 analysts
Est. EPS $0.06 · Revenue $130.07M · 1 analysts
$0.15 per share
$0.15 per share
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $342.3M | -3.3% | +1.4% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-57.6M | +69.6% | -24.3% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +36.0% | -3.6% | -106.5% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +1.0% | +102.8% | -13.2% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -16.8% | +68.6% | -22.5% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $-21.8M | +78.6% | +333.9% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | -6.4% | +77.9% | +327.7% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 174.2% | +3.7% | -53.9% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 0.24x | +8.4% | +142.2% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $1.7B | -12.0% | +16.4% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -2.51 vs -2.60 | +3.5% | -0.13 vs 0.06 | -336.4% |
| Revenue Surprise | $342.3M vs $342.1M | +0.0% | $87.5M vs $127.5M | -31.3% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Campbell Albert M III | director | Common Stock | A | 4,693 | — |
| Aug 10, 2026 | Campbell Albert M III | director | Common Stock | — | 0 | — |
| May 15, 2026 | MICHELSON LESLIE D | director | LTIP Units | A | 7,446 | — |
| May 15, 2026 | Humphrey Scott | director | LTIP Units | A | 9,935 | — |
| May 15, 2026 | Weil Edward M Jr. | director | LTIP Units | A | 7,446 | — |
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Michael R. Anderson | President, CEO & Director | USD 2,690,000 | Male | 1989 | Active |
Andrew T. Babin | CFO & Treasurer | USD 466,671 | Male | 1984 | Active |
Michelle Stepinsky | Senior Vice President of Sales & Marketing | — | Female | — | Active |
Lindsay Gordon | Executive VP & Head of Senior Housing | — | Female | — | Active |
Jie Chai | Executive VP, General Counsel & Secretary | — | Male | — | Active |
Ailin Park | Executive VP & Chief Accounting Officer | — | Female | — | Active |
Michael Taylor | Executive Vice President of Asset Management | — | Male | — | Active |
Boris Korotkin | Executive Vice President of Capital Markets & Corporate Strategy | — | Male | — | Active |
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics
National Healthcare Properties (NASDAQ: NHP) reported second-quarter results marked by continued growth in its senior housing operating portfolio, an expanded acquisition pipeline and lower leverage following its April initial public offering. Chief Executive Officer Michael Anderson said the company's strategy remains focused on growing its senior housing operating portfolio, or SHOP, through acquisitions, concentrating capital in
National Healthcare Properties NASDAQ: NHP reported second-quarter results marked by continued growth in its senior housing operating portfolio, an expanded acquisition pipeline and lower leverage following its April initial public offering.
National Healthcare Properties, Inc. (NHP) Q2 2026 Earnings Call Transcript
NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (the “Company”) (Nasdaq: NHP) announced today that it will redeem all of the outstanding (i) 3,289,061 shares of its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (CUSIP: 42226B204) (the “Series A Preferred Stock”) and (ii) 2,850,427 shares of its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock (CUSIP: 42226B303) (the “Series B Preferred Stock” and, together with the Series A Preferred Stock, the “Outstanding Preferred Stock”), at redemption prices equal to $25.00 per share of Outstanding Preferred Stock, plus any accrued and unpaid dividends thereon to, but not including, September 4, 2026 for the Series A Preferred Stock and October 6, 2026 for the Series B Preferred Stock (each, a “Redemption Date”). The Series A Preferred Stock and the Series B Preferred Stock currently trade under ticker symbols “NHPAP” and “NHPBP”, respectively.
